Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients.
作者:
主题词
药物疗法, 联合(Drug Therapy, Combination);免疫减弱宿主(Immunocompromised Host);抗病毒药(Antiviral Agents);抗体, 单克隆(Antibodies, Monoclonal);复发(Recurrence);人类(Humans);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);老年人(Aged);复方合剂(Drug Combinations);抗体, 中和(Antibodies, Neutralizing);治疗结果(Treatment Outcome)
DOI
10.1093/cid/ciad181
PMID
36976301
发布时间
2023-11-09
- 浏览0

Clinical infectious diseases
280-286页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文